How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?
2013 doctoral thesis by Natalie Gauld at University of Auckland
Press Enter · cited answer in seconds
0 sources
How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?
Summary
How and why do developed countries vary in reclassifying medicines from prescription to non-prescription? is a doctoral thesis[1].
Key Facts
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription? authored Natalie Gauld[2].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s instance of is recorded as doctoral thesis[3].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s publisher is recorded as ResearchSpace@Auckland[4].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s country of origin is recorded as New Zealand[5].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s publication date is recorded as +2013-00-00T00:00:00Z[6].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s work available at URL is recorded as https://researchspace.auckland.ac.nz/handle/2292/21782[7].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s Handle ID is recorded as 2292/21782[8].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s title is recorded as How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?[9].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s copyright holder is recorded as Natalie Gauld[10].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s thesis submitted to is recorded as University of Auckland[11].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s on focus list of Wikimedia project is recorded as NZThesisProject[12].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s copyright status is recorded as copyrighted[13].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s online access status is recorded as open access[14].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s thesis committee member is recorded as Stephen Buetow[15].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s thesis committee member is recorded as Fiona Kelly[16].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s thesis committee member is recorded as Linda Bryant[17].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s thesis committee member is recorded as Stewart Sinclair Jessamine[18].
- How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s thesis committee member is recorded as Lynne Emmerton[19].
Body
Designation and Status
How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?'s instance of is recorded as doctoral thesis[3].